Fremont
Boehringer Ingelheim Fremont, Inc. is the rapidly growing U.S. arm of BI’s Biopharmaceuticals Business Unit. With a diverse team of over 500 people, we cover biopharmaceutical development and manufacturing from small scale to commercial, from drug substance manufacturing to fill/finish, packaging and medical device assembly. Everything we do, we do to help patients - through the reliable supply of high quality medicines, and being on the cutting edge of technology and innovation.
Links
BI BioXcellence
Read more
Related Content
BI US Biopharma
Boehringer Ingelheim Fremont Employee Benefit Highlights
Read more